Concepedia

Rujuta A. Bam

RA

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

2013

Affiliations

Gilead Sciences (United States)(Current)

Rujuta A. Bam is an author at Gilead Sciences (United States) specializing in antiviral therapy, pharmacology, and antiretroviral therapy.

Publications per year

2013–2020

9

Publications

9

Clinical targeting of HIV capsid protein with a long-acting small molecule

John O. Link, Martin S. Rhee, Winston C. Tse et al. · Nature · 2020 · 421 citations · Full text

, , +12

Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile

Manuel Tsiang, G.S. Jones, Joshua Goldsmith et al. · Antimicrobial Agents and Chemotherapy · 2016 · 283 citations · Full text

, , +17

Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells

M. Balakrishnan, Stephen R. Yant, Luong Tsai et al. · PLoS ONE · 2013 · 128 citations · Full text

, , +17

Tenofovir Alafenamide is Not a Substrate for Renal Organic Anion Transporters (Oats) and Does Not Exhibit Oat-Dependent Cytotoxicity

Rujuta A. Bam, Stephen R. Yant, Tomáš Cihlář · Antiviral Therapy · 2013 · 100 citations

, , +17

Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors

Gabriel Birkuš, Rujuta A. Bam, Madeleine Willkom et al. · Antimicrobial Agents and Chemotherapy · 2015 · 71 citations · Full text

, , +17

1–5 of 9